share_log

Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Noonberg Sarah B.

SEC announcement ·  May 17, 2023 21:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more